Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
暂无分享,去创建一个
Yasumasa Nishimura | Masahiko Okumura | Ryuta Koike | Y. Nishimura | M. Okumura | K. Nakamatsu | S. Kanamori | Toru Shibata | Minoru Suzuki | Kiyoshi Nakamatsu | Shuichi Kanamori | Minoru Suzuki | T. Shibata | Ryuta Koike
[1] Radhe Mohan,et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. , 2004, International journal of radiation oncology, biology, physics.
[2] P. Jakobsson,et al. Pre-irradiation qualities of a parotid gland predicting the grade of functional disturbance by radiotherapy. , 1972, Acta oto-laryngologica.
[3] K. Chao. Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer. , 2002, Seminars in radiation oncology.
[4] Harold O. Wyckoff,et al. International Commission ON Radiation Units and Measurements (ICRU). , 1974, The American journal of roentgenology, radium therapy, and nuclear medicine.
[5] E. B. Butler,et al. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. , 2003, International journal of radiation oncology, biology, physics.
[6] K. Mossman. Quantitative radiation dose-response relationships for normal tissues in man. II. Response of the salivary glands during radiotherapy. , 1983, Radiation research.
[7] J. Deasy,et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. , 2001, International journal of radiation oncology, biology, physics.
[8] C. Perez,et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] P. Xia,et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. , 2001, International journal of radiation oncology, biology, physics.
[10] L. Dawson,et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. , 2003, International journal of radiation oncology, biology, physics.
[11] K. Ang,et al. Target cell and mode of radiation injury in rhesus salivary glands. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] R K Ten Haken,et al. Partial irradiation of the parotid gland. , 2001, Seminars in Radiation Oncology.
[13] Y. Nishimura,et al. Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancer. , 2003, Japanese journal of clinical oncology.
[14] R. Henriksson,et al. Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort. , 1992, European journal of cancer.
[15] L. Dawson,et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.
[16] Y. Nishimura,et al. Feasibility study of the simultaneous integrated boost (SIB) method for malignant gliomas using intensity-modulated radiotherapy (IMRT). , 2003, Japanese journal of clinical oncology.